Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase EARLY_PHASE1 2Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 27Breast Neoplasms 23Neoplasms 22Pancreatic Neoplasms 19Prostatic Neoplasms 17Glioma 17Glioblastoma 16Leukemia, Myeloid, Acute 15Recurrence 14Solid Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma 8Hematologic Neoplasms 8Melanoma 7Lymphoma, B-Cell 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Advanced Solid Tumors 7Polycystic Ovary Syndrome 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Stomach Neoplasms 5Myelodysplastic Syndromes 5Leukemia, Plasma Cell 5

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × Solid Cancer × Clear all
NCT07242417 2026-01-21

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

Beijing GoBroad Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Gastrointestinal

Solid Cancer

NCT06697665 2024-11-20

An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours

Suzhou BlueHorse Therapeutics Co., Ltd.

Phase EARLY_PHASE1 Recruiting
10 enrolled

Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡